Key result
FDG-PET/CT detected local relapse in 100% (7/7) of patients and distant metastases in 77% (10/13) of pediatric sarcoma patients with suspected recurrence.
Why the study?
Does FDG-PET/CT improve the detection of local recurrence and distant metastases in children with sarcoma compared to conventional imaging?
Observational (n=19)
Does FDG-PET/CT improve the detection of local recurrence and distant metastases in children with sarcoma compared to conventional imaging?
FDG-PET/CT is a useful complementary imaging modality for detecting recurrent pediatric sarcomas, particularly at the primary site.
This is the authors' abstract. We don't add key points for this paper.
BACKGROUND: Combined positron emission tomography with (18)fluoro-deoxyglucose and computed tomography (FDG-PET/CT) has been used in the diagnosis and staging of various malignancies, but their use in the management of pediatric sarcomas is less well defined. The potential role of FDG-PET/CT in the diagnosis of local recurrence and distant metastases of pediatric sarcomas was investigated. PROCEDURE: Nineteen children (aged 2-21) with sarcoma (9 Ewing sarcoma, 3 osteogenic sarcoma, 7 rhabdomyosarcoma) were evaluated between January 2000 and December 2005 by FDG-PET/CT for suspected local relapse or distant metastases. The results of 21 FDG-PET studies, 16 CT scans, 9 magnetic resonance imaging (MRI) studies, and 7 bone scans (BSs) were compared with surgical pathology or clinical follow-up for at least 3 months. RESULTS: FDG-PET detected local relapse in all seven patients and distant metastases in 10/13 (77%). FDG-PET/CT and CT/MRI/BS results were discordant in eight patients. FDG-PET/CT was the only modality that detected distant metastases in two patients. PET/CT was true negative and excluded disease in three patients with abnormal CT/BSs and was false negative in three patients with distant metastases. CONCLUSION: FDG-PET/CT may be useful and complementary to other imaging modalities for the detection of recurrent pediatric sarcomas, especially at the primary site. Its potential advantages and limitations compared with conventional imaging modalities need to be further investigated in larger homogenous patient groups.
Answers are grounded in this paper and cite their sources.
Supports FDG-PET/CT as complementary for suspected recurrence in pediatric sarcomas; leaves open prospective comparison to conventional imaging.
No takes yet. Share an insight, caveat, or question.
Arush et al. (2007) conducted an observational in Pediatric sarcoma (n=19). FDG-PET/CT vs. Conventional imaging (CT, MRI, bone scans) was evaluated on Detection of local recurrence and distant metastases. FDG-PET/CT detected local relapse in 100% (7/7) of patients and distant metastases in 77% (10/13) of pediatric sarcoma patients with suspected recurrence.
Synapse has enriched 10 related papers. Consider them for comparative context: